FDA gives green light to America Stem Cell transplant trial

09/5/2013 | American City Business Journals

The FDA has granted America Stem Cell approval to conduct a Phase I/IIa multicenter dual umbilical cord transplantation study. The nationwide trial will assess the efficacy of the firm's investigational therapy ASC-101 in patients with hematologic malignancies and myelodysplastic syndrome.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
K-12 Teachers Needed at Int’l Schools
The International Educator
Multiple Locations
Instructional Designer, ESL
Imagine Learning, Inc.
Provo, UT
Sr. Product Manager - Professional Development
NWEA
Nationwide, SL_Nationwide
Sr. Product Manager - Formative Assessment Product Line
NWEA
Nationwide, SL_Nationwide
Account Executive
NWEA
Multiple Locations, SL_Multiple Locations